Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Risedronate sodium; Calcium carbonate; Colecalciferol; cholecalciferol
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
_Risedronate sanofi-aventis Combi D CMI _ _REG _ _#_ _ _ _102972v2.0_ _ _ _Page _ _1_ _ _ _ _ Risedronate sanofi-aventis Combi D _RISEDRONATE SODIUM, CALCIUM CARBONATE, CHOLECALCIFEROL (VITAMIN D3) _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Risedronate sanofi- aventis Combi D. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Risedronate sanofi-aventis Combi D against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT RISEDRONATE SANOFI-AVENTIS COMBI D IS USED FOR Risedronate sanofi-aventis Combi D is used to treat bone disease. Risedronate sanofi-aventis Combi D works directly on your bones to make them stronger and therefore less likely to break or fracture. Risedronate sanofi-aventis Combi D is a combination medicine consisting of risedronate sodium, calcium carbonate and cholecalciferol (Vitamin D3). Each week of therapy includes: One Risedronate sanofi-aventis 35mg Once-a-Week tablet (the small light- orange tablet) and 6 sachets containing calcium carbonate 2500mg and cholecalciferol 22mcg (Vitamin D3 880 IU). The active ingredient in Risedronate sanofi-aventis 35mg tablets is called risedronate sodium and belongs to a group of medicines called bisphosphonates. Risedronate sanofi-aventis 35mg tablets are used to treat: osteoporosis (brittle or fragile bones that may fracture easily) osteoporosis caused by taking steroids The calcium carbonate contained in the sachet helps to supply the calcium you Read the complete document
_Risedronate sanofi-aventis _ _#_ 102898 v2.0 _ _ _Page 1 _ PRODUCT INFORMATION RISEDRONATE SANOFI-AVENTIS ® , RISEDRONATE SANOFI-AVENTIS COMBI & RISEDRONATE SANOFI-AVENTIS COMBI D NAME OF THE MEDICINE NON-PROPRIETARY NAME Risedronate Each Risedronate sanofi-aventis tablet contains the equivalent of 5, 30, 35 or 75, or 150 mg of risedronate sodium. The empirical formula for risedronate sodium is C 7 H 10 NO 7 P 2 Na. The chemical name of risedronate sodium is [1-hydroxy-2-(3- pyridinyl)ethylidene]bis(phosphonic acid) monosodium salt. Calcium Carbonate Tablet Also contains 1250 mg calcium carbonate tablets. Each calcium tablet contains 1250 mg calcium carbonate, which is equivalent to 500 mg elemental calcium. Calcium Carbonate/Cholecalciferol Sachet Each sachet contains 2500 mg calcium carbonate and 22 g (880 IU) cholecalciferol, which is equivalent to 1000 mg elemental calcium and 22 g (880 IU) vitamin D3. The terms cholecalciferol and vitamin D3 are equivalent. The chemical name of cholecalciferol is (5Z,7E)-9,10- secocholesta-5,7,10(19)-trien-3β-ol. Molecular formula: C 27 H 44 O. CHEMICAL STRUCTURE The chemical structure of risedronate sodium is the following: Molecular Weight: 305.10 The CAS registry number is 115436-72-1 The chemical structure of cholecalciferol: Molecular Weight: 384.6 The CAS registry number is 67-97-0 DESCRIPTION Risedronate sodium is a fine, white to off-white, odourless, crystalline powder. It is soluble in water and in aqueous solutions and essentially insoluble in common organic solvents. Calcium carbonate is a white powder, practically insoluble in water, with a relative molecular _Risedronate sanofi-aventis _ _#_ 102898 v2.0 _ _ _Page 2 _ weight of 100.1. Cholecalciferol is a secosterol that is a natural precursor of the calcium-regulating hormone calcitriol (1,25-dihydroxy Read the complete document